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Abstract
Background: To identify molecular mechanisms underlying SCN5A-related sick sinus syndrome (SSS), a rare type of SSS, in
parallel experiments we elucidated the electrophysiological properties and the cell surface localization of thirteen human
Nav1.5 (hNav1.5) mutant channels previously linked to this disease.
Methodology/Principal Findings: Mutant hNav1.5 channels expressed by HEK293 cells and Xenopus oocytes were
investigated by whole-cell patch clamp and two-microelectrode voltage clamp, respectively. HEK293 cell surface
biotinylation experiments quantified the fraction of correctly targeted channel proteins. Our data suggested three distinct
mutant channel subtypes: Group 1 mutants (L212P, P1298L, DelF1617, R1632H) gave peak current densities and cell surface
targeting indistinguishable from wild-type hNav1.5. Loss-of-function of these mutants resulted from altered channel
kinetics, including a negative shift of steady-state inactivation and a reduced voltage dependency of open-state
inactivation. Group 2 mutants (E161K, T220I, D1275N) gave significantly reduced whole-cell currents due to impaired cell
surface localization (D1275N), altered channel properties at unchanged cell surface localization (T220I), or a combination of
both (E161K). Group 3 mutant channels were non-functional, due to an almost complete lack of protein at the plasma
membrane (T187I, W1421X, K1578fs/52, R1623X) or a probable gating/permeation defect with normal surface localisation
(R878C, G1408R).
Conclusions/Significance: This study indicates that multiple molecular mechanisms, including gating abnormalities,
trafficking defects, or a combination of both, are responsible for SCN5A-related familial SSS.
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Introduction
Sick sinus syndrome (SSS) was first described nearly 40 years
ago by Lown as a complicating arrhythmia following cardiover-
sion [1]. Today SSS (also called sinus node dysfunction, SND)
refers to abnormalities in sinus node impulse formation and
propagation, including sinus bradycardia, sinus pause/arrest,
chronotropic incompetence, and sinoatrial exit block [2]. SSS is
frequently associated with conduction system disease in the heart
and various supraventricular tachyarrhythmias, such as atrial
fibrillation and atrial flutter. When associated with supraventric-
ular tachyarrhythmias, SSS is often termed tachy-brady syn-
drome [2]. SSS accounts for approximately 50% of the million
permanent pacemaker implants per year worldwide [3]. SSS may
be associated with underlying cardiac disease conditions includ-
ing any form of acquired heart disease (e.g. coronary artery
disease, cardiomyopathies and valvular heart disease), and occurs
following surgical injury. However, SSS most commonly occurs
in the elderly in the absence of an apparent accompanying heart
disease [4].
Voltage-gated Na
+ channels mediate the rapid upstroke of the
action potential in excitable tissues. Nav1.5, encoded by the
SCN5A gene, is the predominant isoform in the heart of higher
mammals [5,6]. Mutations in SCN5A have been linked to various
cardiac arrhythmic syndromes ranging from acute life-threaten-
ing tachyarrhythmias to bradyarrhythmias: the congenital long
QT syndrome subtype 3 (LQT3) [7,8], Brugada syndrome (BrS)
[9–11], isolated cardiac conduction disease (CCD) [12], and
sudden infant death syndrome (SIDS) [13].
Recently, a number of studies have linked genetic defects in
ion channels, including human Nav1.5 (hNav1.5), to familial
SSS. To date, fourteen SCN5A mutations have been associated
with this disease [14,15]. Although SCN5A-related familial SSS
is rare, reports have conclusively demonstrated that hNav1.5
plays essential roles in the excitation of atrial and ventricular
myocytes, and in impulse generation and propagation by the
sinus node [14,16–20]. Clinical data on SCN5A-related SSS are
strongly supported by several experimental results. Transcrip-
tion and expression of Nav1 . 5m R N Aa n dp r o t e i nr e s p e c t i v e l y
in the human peripheral sinus node was demonstrated recently
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+ currents were recorded in sinus
node pacemaker cells from both mammalian animals [14,22]
and humans [23]. Importantly, reduced Na
+ channel expression
in the hearts of heterozygous SCN5A
+/2 mice resulted in sinus
bradycardia, slowed sinoatrial conduction, and sinoatrial
exit block; these phenomena are also observed in SSS patients
[24].
Most of these SSS-related mutant channels have been
expressed by different heterologous host cells including mamma-
lian cell lines and Xenopus oocytes, and several loss-of-function
features have been identified [22]. However, electrophysiological
recordings have not yet been combined with biochemistry
techniques that enable quantitative estimation of the localization
of mutant channel proteins at the plasma membrane. Together,
these data would enable discrimination between electrical defects
of correctly targeted mutant channels and impaired subcellular
localization. Furthermore, none of the mutant channels has been
expressed by parallel systems in the same lab. Previous studies, for
example results for BrS mutation T1620M [25], suggest that loss-
of-function properties depend on the expression system chosen.
Similarly, minor defects were observed for the familial SSS-
related mutant channel D1275N when expressed by Xenopus
oocytes [17]; however, it has been speculated that more severe
defects might be observed upon expression by a mammalian cell
line [26,27].
In this study, we have investigated the molecular mechanisms
underlying loss-of-function of hNav1.5 mutant channels associat-
ed with familial SSS. The first aim was to investigate both the
electrophysiological properties and the plasma membrane
localization of thirteen mutant channels in HEK293 cells: This
would enable us to discriminate between protein targeting and
electrophysiological defects. The second aim was to compare the
electrophysiological properties of nine selected mutant channels
expressed by both HEK293 cells and Xenopus oocytes: This would
identify any dependence of results upon these commonly used
expression systems. Our results provide novel insights into the
multiplicity of molecular mechanisms underlying SCN5A-related
SSS, and hence a better understanding of genotype-phenotype
correlations for this rare channelopathy.
Results
Electrophysiological properties of mutant hNav1.5
channels in HEK293 cells
Thirteen hNav1.5 mutants previously identified in familial SSS
patients were expressed heterologously by HEK293 cells and
characterized by whole-cell patch clamp recordings. For ease of
description, these mutants were classified into three groups
according to the size of the whole-cell Na
+ currents (Fig. 1).
Group 1 mutants (L212P, P1298L, DelF1617, and R1632H)
generated peak Na
+ currents comparable to those observed for
wild-type hNav1.5 (Table 1, Figs. 1A and 2A). Group 2 mutants
(E161K, T220I, and D1275N) produced significantly reduced but
detectable whole-cell Na
+ currents (Table 1, Figs. 1B and 3A).
Group 3 mutants (T187I, R878C, G1408R, W1421X, K1578fs/
52, and R1623X) did not produce any detectable Na
+ inward
current (Fig. 1C).
A feature common to all group 1 mutants was a significant shift
of steady-state inactivation towards hyperpolarized potentials
(Table 1, Fig. 2C). This is likely to result in reduced channel
availability in patients’ cardiomyocytes. The largest shift of the
mid-inactivation potential was observed for R1632H (220.7 mV).
Shifts of 210.5 mV, 210.6 mV, and 28.9 mV were recorded for
L212P, DelF1617, and P1298L respectively. The left-shift of
steady-state inactivation was accompanied either by an unchanged
steady-state activation (P1298L, R1632H) or by a left-shift of
steady-state activation (215.0 mV for L212P, 26.8 mV for
DelF1617; Table 1, Fig. 2B). Left-shifts of steady-state activation
towards hyperpolarized potentials may partially antagonize loss-of-
function caused by reduced channel availability. Recovery from
inactivation by group 1 mutants was unchanged (L212P, P1298L),
slightly accelerated (DelF1617), or dramatically decelerated
(R1632H; Fig. 2D). Full recovery of R1632H at 2120 mV took
5 seconds. This suggests that most R1632H channels are
inactivated at physiological membrane potentials and normal
heart rates.
When considering inactivation time constants as a function of
the membrane voltage (Fig. 2E and 2F), we observed a second
feature common to all group 1 mutants: The voltage dependency
Figure 1. Representative HEK293 whole-cell current recordings for hNav1.5 and SSS-associated mutants. (A) Group 1 mutants
produced peak current densities similar to wild-type hNav1.5. (B) Group 2 mutants produced reduced currents. (C) Group 3 mutants produced no
current. Table 1 shows average peak current densities and statistics thereof.
doi:10.1371/journal.pone.0010985.g001
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current decay and hence loss-of-function at less depolarized
membrane potentials. In addition, DelF1617 and R1632H
displayed inactivation defects at more depolarized membrane
voltages and hence a potential gain-of-function mechanism
(Fig. 2F). For L212P, lower inactivation time constants at more
negative potentials can be at least partially explained by the
pronounced negative shift of the mid-activation potential by
215 mV (Fig. 2E).
In contrast to the clear hyperpolarizing shift of steady-state
inactivation seen with group 1 mutant channels, availability of
group 2 mutants was either unchanged (E161K, D1275N) or only
slightly reduced (shift by 25.6 mV for T220I; Table 1, Fig. 3C).
Steady-state activation curves were shifted by +19.8 mV and
+3.1 mV towards depolarizing potentials for E161K and D1275N,
respectively (Table 1, Fig. 3B). Positive shifts were not observed for
group 1 mutants. In addition to the reduced current densities, the
positive shifts of steady-state activation can be expected to further
impair excitability of cardiomyocytes [28]. Steady-state activation
was unchanged for T220I only. Recovery from inactivation for
group 2 mutants was unchanged (E161K), slightly decelerated
(T220I), or accelerated (D1275N; Table 1, Fig. 3D). We found
slightly reduced and unchanged voltage dependency of channel
inactivation time constants for T220I and D1275N, respectively.
For E161K, slower channel inactivation at potentials from 240 to
0 mV can be at least partially explained by the clear positive shift
by nearly 20 mV of the mid-activation potential (Fig. 3B).
Electrophysiological properties of hNav1.5 mutant
channels in Xenopus oocytes
In some previous reports, differences between electrophysiolog-
ical properties reported for the same hNav1.5 mutant channel
were attributed to the use of different expression systems [25].
Compared to Xenopus oocytes, HEK293 or CHO expression
systems are often considered more reliable because of their
mammalian origin and because of their cultivation at body core
temperature. Xenopus oocytes injected with mutant cRNA are
incubated for several days at 18uC, which may stabilize mutant
channels resulting in a partial restoration of functional surface
expression. In order to investigate whether similar electrophysiol-
ogy results would be obtained from mutant channels expressed by
Xenopus oocytes, we selected nine out of the thirteen SSS-related
mutations, injected oocytes with wild-type and mutant cRNA, and
measured whole-cell currents using the two-microelectrode voltage
clamp technique.
For all group 3 mutant channels tested (T187I, R878C,
G1408R, W1421X), we were unable to detect any Na
+ current
even after injecting undiluted cRNA, supporting our data from
HEK293 cells. Neither the lower incubation temperature nor a
high cRNA concentration could restore functional expression. For
the other channel variants, classified upon expression by HEK293
cells as group 1 mutants (L212P, P1298L) or group 2 mutants
(E161K, T220I, D1275N), we also observed data similar to those
obtained from HEK293 cells (Fig. 4, Table 2). Only a few results
differed from those obtained from transfected HEK293 cells: First,
normalized peak currents obtained from oocytes were significantly
smaller for E161K, D1275N and even for P1298L, which was
classified as a group 1 mutant according to results from HEK293
cells (Figs. 1 and 4). For E161K, currents were clearly above
background but too small to ensure a reliable evaluation of
channel kinetics. Second, the mid-inactivation potential for
D1275N was shifted towards hyperpolarized potentials only for
oocytes, suggesting a contribution of reduced channel availability
to the patients’ phenotype. Third, recovery from inactivation by
L212P was decelerated in oocytes but not in HEK cells, indicating
that only the oocyte expression system revealed this potential loss-
of-function mechanism. Fourth, minor differences between the
two expression systems were as follows: a slightly altered slope of
the steady-state activation curve for D1275N channels in oocytes
only; a slightly altered slope of the steady-state inactivation curve
for P1298L channels in HEK293 cells only; and a slight increase of
the fast recovery time constant for T220I channels in HEK293
cells (compare Tables 1 and 2).
In conclusion, during comparisons between SSS-related mutant
channels and wild-type hNav1.5, most of the electrophysiological
parameters obtained from oocytes were not different from
respective results obtained from HEK293 cells (Tables 1 and 2).
Notably, for three out of the four mutant channels that showed
expression system-dependent properties, more severe loss-of-
function features were associated with oocytes: This suggests that
results from oocytes may account better for cardiac excitation
abnormalities observed in familial SSS.
Table 1. Electrophysiological properties of wild-type and mutant hNav1.5 channels in HEK293 cells.
Channel peak currrent Steady-state activation Steady-state inactivation Recovery from inactivation
density (pA/pF) k (mV) V1/2 (mV) n k (mV) V1/2 (mV) n tf (ms) Af ts (ms) As n
hNav1.5 2866.5679.8 6.960.2 234.760.7 23 26.460.1 281.460.7 24 6.960.3 0.8960.01 149.2611.8 0.1160.01 20
Group 1 mutants
L212P 2805.3676.7 8.060.3
m 249.760.8
m 22 25.560.1
m 291.960.8
m 28 7.560.4 0.8660.02 159.9612.1 0.1460.02 19
P1298L 2789.6684.0 7.260.2 235.260.6 19 26.860.1* 290.360.6
m 24 7.460.3 0.9060.01 194.6617.0 0.1060.01 22
DelF1617 2687.8664.9 7.960.2
m 241.561.2
m 24 26.760.1 292.061.1
m 25 6.060.4* 0.8060.01
m 108.468.39* 0.1960.01
m 18
R1632H 21105.66112.0 7.060.2 236.160.8 21 27.260.1
m 2102.160.9
m 25 114.3611.8
m 0.2860.02
m 695.8636.4
m 0.7260.02
m 23
Group 2 mutants
E161K 2203.7630.8
m 9.060.1
m 214.960.7
m 19 26.660.1 279.960.9 21 6.560.4 0.8660.02 192.3647.8 0.1260.02 14
T220I 2533.8656.6* 7.360.1 235.760.7 25 26.560.1 287.060.8
m 30 8.060.4* 0.8660.01 123.268.8 0.13760.01 21
D1275N 2575.0657.6* 6.860.2 231.660.8
m 18 25.560.1
m 279.660.6 21 3.960.1
m 0.8960.01 140.4610.4 0.10760.01 23
*indicates p,0.05 versus hNav1.5.
mindicates p,0.01 versus hNav1.5.
doi:10.1371/journal.pone.0010985.t001
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PLoS ONE | www.plosone.org 3 June 2010 | Volume 5 | Issue 6 | e10985Figure 2. Electrophysiological properties of four group 1 mutant channels expressed by HEK293 cells. Individual parameters are
summarized in Table 1. (A) Peak current-to-voltage (I–V) relationships. Currents were elicited from the holding potential of 2120 mV to the test
potentials indicated. (B) Steady-state activation as a function of voltage. (C) Steady-state inactivation as a function of voltage. (D) Recovery from
inactivation. Normalized data were fitted to double exponentials yielding the fast and slow time constants listed in Table 1. (E, F) Time constant of
inactivation (th) as a function of voltage. Parameters were obtained from monoexponential fits. Error bars represent the mean 6 SEM.
doi:10.1371/journal.pone.0010985.g002
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surface biotinylation experiments
We performed cell surface biotinylation experiments in
conjunction with Western blotting using HEK293 cells transfected
with the thirteen familial SSS-related mutants. For each mutant,
the fraction of correctly targeted channel to the total cellular
channel pool was determined and normalised with the corre-
sponding fraction determined for wild-type from the same blot.
Each calculation was performed in (at least) triplicate to enable the
determination of statistically significant differences. Representative
Western blots are shown in Fig. 5; normalized cell surface signals
are shown alongside peak current densities in Fig. 6.
As expected from our whole-cell current measurements of
HEK293 cells, all group 1 mutants were present at the plasma
membrane in quantities similar to that for wild-type hNav1.5. For
group 2 mutants, which generated smaller whole-cell currents
Figure 3. Electrophysiological properties of three group 2 mutant channels expressed by HEK293 cells. Individual parameters are
summarized in Table 1. (A) Peak current-to-voltage (I–V) relationships. Currents were elicited from the holding potential of 2120 mV to the indicated
test potentials. (B) Steady-state activation as a function of voltage. (C) Steady-state inactivation as a function of voltage. (D) Recovery from
inactivation. (E) Time constant of inactivation (th) as function of voltage. Error bars represent the mean 6 SEM.
doi:10.1371/journal.pone.0010985.g003
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unchanged (T220I) cell surface signals when compared to wild-
type hNav1.5 (Fig. 6). For D1275N, the normalized cell surface
signal was reduced to 68.0%. Interestingly, this reduction in
channel number was in close agreement with the reduction of the
peak current density to 66.3%. For E161K, the cell surface signal
was reduced to ,70%, but peak current amplitudes were reduced
to ,30% (Fig. 6). Consequently, the reduction in current density
cannot solely be explained by the reduction in channel number at
the plasma membrane. T220I showed no change in cell surface
expression despite having a reduction in peak current to 61.6%
(Fig. 6). Together, these data suggest that altered single channel
properties are responsible for reduced whole-cell currents for both
E161K and T220I, a hypothesis that remains to be tested.
For the non-functional group 3 mutants we noticed two distinct
channel subtypes. First, normal surface localization was observed
for R878C and G1408R, suggesting that these mutations affected
channel gating or permeation properties rather than intracellular
channel maturation and trafficking. Second, very small fractions of
the mutant T187I and the shortened variants W1421X, K1578fs/
52, and R1632X were detected at the plasma membrane.
Consequently, these mutants are largely trafficking-deficient.
Discussion
This study evaluated cell surface localization of thirteen hNav1.5
mutant channels previously linked to familial SSS, and correlated
these data with the electrophysiological properties of the mutant
channels. Whereas several electrophysiological parameters for
some of the mutant channels have been reported by other groups,
little or no information was available on the contribution of
possible maturation/trafficking defects to losses-of-function for the
mutants. Hence, this study provides new mechanistic insight into
the pathogenesis of SCN5A-related familial SSS.
Loss-of-function mechanisms
This study revealed four distinct loss-of-function mechanisms for
the mutant hNav1.5 channels (Fig. 7): First, mutants R878C and
G1408Rwerecorrectlytransportedtotheplasmamembrane,butdid
not form functional channels, suggesting a complete gating/
permeation defect. Our data on R878C and G1408R are in good
agreement with previous electrophysiological, GFP-labeling and
immunohistochemical studies that demonstrated surface localization
of non-functional channels [29,30]. Second, several mutant channels
(L212P, T220I, P1298L, DelF1617, and R1632H) with normal
presence at the plasma membrane displayed affected kinetics
(Tables 1 and 2). For example, R1632H exhibited normal surface
localization with peak current densities comparable to those for wild-
type hNav1.5 (Fig. 1A); however, the strongly reduced steady-state
availability in combination with a dramatically decelerated recovery
is likely to result in non-functional channels under physiological
conditions (Table 1, Fig. 2). This mutation was first reported by
Benson et al. who found similar electrophysiological defects in tsA201
cells [16]. Third, some mutant channels (T187I and all truncated
variants) were non-functional because of almost completely deficient
maturation/trafficking (Figs. 1 and 6). Previous studies on these
mutant channels also reported non-functional expression, but did not
specify trafficking-deficiencies [16,31]. For the truncated variants,
intracellular protein retention was not surprising. Interestingly, we
consistently observed a much weaker signal from the total cellular
extracts for W1421X (see the example in Fig. 5), suggesting that the
shortened channel proteins were subjected to enhanced intracellular
degradation. However for T187I, only a single amino acid exchange
led to a near-complete intracellular retention, whilst levels of the
intracellular T187I pool were comparable to wild-type hNav1.5
Figure 4. A comparison of normalized peak current amplitudes
for wild-type and mutant hNav1.5 channels expressed by two
different expression systems. Whole-cell currents were recorded by
the patch clamp technique (HEK293 cells) and by the two-microelec-
trode voltage clamp technique (oocytes) as described in ‘‘Methods’’.
L212P and T220I exhibited similar relative expression levels in both
systems. With E161K, D1275N, and P1298L, whole-cell currents,
normalized to hNav1.5 values, were significantly smaller for the oocyte
system (* indicates p,0.01). Channels classified as group 3 mutants
upon expression by HEK293 cells (T187I, R878C, G1408R, W1421X) did
not produce detectable Na
+ inward currents in the oocyte system, even
upon injection of undiluted cRNA (data not shown).
doi:10.1371/journal.pone.0010985.g004
Table 2. Electrophysiological properties of wild-type and mutant hNav1.5 channels in Xenopus oocytes.
Channel Normalized Steady-state activation Steady-state inactivation Recovery from inactivation
peak currrent n k (mV) V1/2 (mV) n k (mV) V1/2 (mV) n tf (ms) Af ts (ms) As n
hNav1.5 1.0060.04 75 3.660.1 234.260.6 22 25.560.1 267.760.5 31 4.860.3 1.1660.02 159.3622.2 0.0960.01 24
L212P 1.0160.08 56 4.360.1
m 246.560.5
m 22 24.860.1
m 282.160.3
m 25 5.760.2* 1.1460.01 319.0644.3
m 0.0960.01 24
T220I 0.7560.04
m 62 3.760.1 235.160.4 24 25.660.1 273.560.5
m 28 5.060.4 1.1760.02 115.4617.2 0.0760.01 15
D1275N 0.2860.03
m 37 4.160.1
m 232.260.4
m 19 24.960.1
m 271.260.6
m 15 3.860.3* 1.1960.02 187.7625.9 0.0960.01 14
P1298L 0.5960.03
m 47 3.860.1 234.360.3 21 25.460.1 276.960.5
m 26 5.460.2 1.1660.01 229.9630.8 0.0960.01 21
*indicates p,0.05 versus hNav1.5.
mindicates p,0.01 versus hNav1.5.
doi:10.1371/journal.pone.0010985.t002
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could neither be restored by mexiletine treatment nor by co-
expression of the b1 subunit [31]. A screen for known protein motifs
intheaffectedS2–S3linkerindomainIwasunsuccessful.Wenoticed
that the distal half of this linker that included threonine 187 is highly
conserved among voltage-gated Na
+ channels. It is possible that this
linker region, which is located intracellularly, contains an unknown
ER export signal. Fourth, loss-of-function can also be attributed to
both a partial trafficking defect and alterations of channel kinetics, as
observed for E161K and D1275N (Tables 1 and 2). For E161K, the
reduction of the cell surface biotinylation signal was much less
pronounced than the reduction of the whole-cell current (Fig. 5),
suggesting impaired single channel properties even for correctly
targeted mutant channels.
Association of loss-of-function of hNav1.5 mutants to
familial SSS and to other cardiac excitation disorders
Classifications of hNav1.5 mutant channels according to current
densities or trafficking properties are less helpful when explaining
Figure 5. Representative Western blots showing Nav1.5 polypeptides purified from the surface of HEK293 cells by the
biotinylation/precipitation procedure (cell surface) and the Nav1.5 polypeptides in HEK293 cell lysates (total). Calnexin was used as a
control to demonstrate the absence of endoplasmic reticulum membranes in the isolated plasma membrane fraction.
doi:10.1371/journal.pone.0010985.g005
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because such reflections do not account for a possible age-dependent
onset of the disease, for other accompanying cardiac rhythm
disorders, or for additional risk factors that contribute towards SSS.
In Table 3, we summarize the distinct SCN5A genotypes, the
corresponding patients’ phenotypes, and major biochemical and
electrophysiological properties of the thirteen hNav1.5 mutant
channels investigated in this study. A strong correlation between a
defective hNav1.5 channel and familial SSS was found in patients
carrying compound heterozygous SCN5A mutations (P1298L/
G1408R, DelF1617/R1632H, and T220I/R1623X) [16]. These
patients experienced an early onset of SSS (Table 3), and no other
excitation disorders have been reported to date. In each of these
three cases, one of the mutants was characterized by mild loss-of-
function (P1298L, DelF1617, and T220I), whereas the second
mutant, produced from the other allele, can be considered as
either severely affected (R1632H) or non-functional (G1408R,
R1623X) [16]. This indicates that sinus node function is affected at
an early developmental stage when the total Na
+ current is
reduced to less than 50% of its maximal value. The parents of the
patients, carrying only one of the six mutations and hence
producing a total of at least 50% of the maximum Na
+ current
from the wild-type plus the affected allele, were either asymptom-
atic or presented with a mild cardiac rhythm disorder (first degree
AV block) [16]. Wild-type hNav1.5 channel activity plus the
residual Na
+ channel activity of some of the mutants were
sufficient to maintain normal cardiac function. However, it must
be mentioned that more severe phenotypes were observed in
unrelated families carrying the heterozygous mutations G1408R,
T220I, or DelF1617 (Table 3) [29,32,33]. Moreover, the
heterozygous mutation R1623X caused a combination of BrS
and SSS in another patient [31]. In contrast to carriers of
compound heterozygous SCN5A mutations, the R1623X carrier
was already 65 years old when he experienced recurrent syncope
due to sinus arrest. Similarly, several carriers of other mutations
(T187I, R878C, W1421X, K1578fs, and E161K) investigated in
this study also presented with other cardiac rhythm disorders, such
as BrS, CCD, or AV block. Most of these patients were adults
when they developed signs of SSS (Table 3). Consequently, a
strong Na
+ current reduction, arising from SCN5A haploinsuffi-
ciency, can result in sinus node dysfunction, but the disease
phenotype is accompanied by other cardiac excitations disorders,
and onset of symptoms occurs at a later ontogenetic stage.
Notably, dozens of other severe loss-of-function mutations in
SCN5A are known to cause BrS, CCD, or both [28]. However,
only a few mutations have been related to sinus node dysfunction,
suggesting that as yet unknown factors other than Na
+ current
reduction and aging contribute to the development of SSS in
carriers of T187I, R878C, W1421X, K1578fs, and E161K.
The importance of other risk factors in SCN5A-related SSS
becomes obvious when considering the striking genotype-pheno-
type disassociation for L212P and D1275N carriers. Atrial
standstill exhibited by the L212P carrier, a three years old boy,
occurred only in combination with a connexin 40 (Cx40)
polymorphism [34]. The father of the index patient, an L212P
carrier lacking this Cx40 variant, exhibited normal sinus rhythm
[34]. The normal cardiac phenotype of this L212P carrier is in
good agreement with the normal trafficking and the mildly
affected electrophysiological properties of L212P channels
(Table 3). Similar observations were reported for D1275N [17]:
The study by Groenewegen et al. suggested a rare Cx40
polymorphism as a prerequisite for atrial standstill in D1275N
carriers [17]. However, D1275N was correlated in unrelated
families to sinus node dysfunction, arrhythmia, and ventricular
dilation [26], to atrial fibrillation, SSS, CCD, and DCM [32], and
to atrial arrhythmia and CCD [27]. The reasons for this spectrum
of disease manifestations are unknown, and it is hard to imagine
that the minor changes of channel kinetics associated with
D1275N are responsible for this variety. Recently, we found that
the common SCN5A polymorphism H558R enhanced trafficking
of D1275N [35]. Consequently, it is reasonable to assume that
several factors, such as polymorphisms in other cardiac genes,
gender differences, modulatory proteins of hNav1.5 [36], and/or
ageing and fibrosis, are important determinants in SCN5A-related
channelopathies, including familial SSS.
Limitations of this study
This study possesses a number of limitations. First, caution
should be taken when extrapolating the findings from this in vitro
Figure 6. Correlation between cell surface expression and peak
current densities for the thirteen SSS-associated mutant
channels. Normalized cell surface signals were obtained by dividing
the ‘‘cell surface’’ signal by the corresponding ‘‘total’’ signal; both
signals being obtained from the same Western blot (see Fig. 5). A ratio
obtained for a mutant was further normalized by dividing with the ratio
obtained for wild-type hNav1.5 again from the same blot. The mean
double-normalized cell surface signals shown were calculated from at
least three independent biotinylation experiments. * indicates p,0.05,
** indicates p,0.01.
doi:10.1371/journal.pone.0010985.g006
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conditions. A bridge to the human in vivo situation might be
provided by genetically modified mouse models that could possibly
provide further information. Second, this study was unable to
examine other contributing factors, such as the fibrosis, the
remodeling of ion channels, and the autonomic dysfunction that
occur as a result of ageing. Third, the effects of different b subunits
upon the biophysical properties and intracellular trafficking of the
Na
+ channel a subunit have not been explored in this study.
Accessory b subunits are well-known modulators of voltage-gated
Na
+ channels, and it is possible that the different b subunits exert
distinct effects on the SSS-associated mutant channels investigated
in this study.
Materials and Methods
Recombinant DNA procedures
Plasmid pSP64T-hH1 encoding hNav1.5 (also called hH1,
accession No. M77235) was kindly provided by Dr. A. L. George
(Vanderbilt University, TN, USA). For expression in HEK293
cells, the hNav1.5 cDNA was subcloned into the pIRES2-EGFP
expression plasmid (Clontech, CA, USA) using SalI/SmaI
restriction sites. All mutations were then introduced by site-
directed mutagenesis (QuikChangeH II XL Site-Directed Muta-
genesis Kits, Stratagene, CA, USA) according to the manufactur-
er’s instructions. DNA constructs were checked by restriction
digests and DNA sequencing.
Transfection and electrophysiological recordings using
HEK293 cells
A human embryonic kidney cell line (HEK293 cell line, CRL-
1573, supplied by American Type Culture Collection, USA) was
cultured in Dulbecco’s Modification of Eagle’s Medium (DMEM,
Lonza, Belgium) supplemented with 10% fetal bovine serum
(Lonza, Belgium), 2 mmol/L L-glutamine, 100 units/mL penicil-
lin, and 100 mg/mL streptomycin. Cells were transfected using a
standard calcium phosphate precipitation method using 0.2 mg
DNA per 35 mm dish) for electrophysiological experiments, or
Lipofectamine (Invitrogen) using 1.5 mg DNA per 60 mm dish for
cell surface biotinylation experiments.
For electrophysiological recordings, HEK293 cells were tryp-
sinized 24 h after transfection and seeded onto a glass coverslip at
a density that enabled single cells to be identified. Whole-cell Na
+
currents were recorded using the patch-clamp technique, a 200B
amplifier (Axon Instruments, Foster City, CA, USA), and with
patch pipettes fabricated from borosilicate glass capillaries
(1.5 mm outer diameter; Fisher Scientific, Pittsburgh, PA, USA).
The pipettes were pulled with a PP-830 gravity puller (Narishige,
Tokyo, Japan), and filled with a pipette solution of the following
composition (in mmol/L): CsCl 130, NaCl 10, HEPES 10, EGTA
10, pH 7.2 (CsOH). Pipette resistance ranged from 1.0 to 2.0 MV
when the pipettes were filled with the internal solution. The
perfusion solution contained (in mmol/L): NaCl 140, KCl 4,
CaCl2 1.8, MgCl2 1.0, HEPES 10, and glucose 10, pH 7.4
(NaOH). Series resistance errors were reduced by approximately
Figure 7. Summary of the molecular mechanisms underlying SCN5A-related familial SSS. (A) Proposed membrane topology of hNav1.5
showing the locations of the thirteen SSS-associated mutations investigated here. Compared to wild-type hNav1.5, the mutant channels produced
either similar (group 1, white), reduced (group 2, light grey) or no (group 3, dark grey) current. (B) Schematic representation of a sinus node cell and
the cellular mechanisms involved in SCN5A-related familial SSS. Early onset of familial SSS occurred (a) when two alleles were affected (compound
mutations P1298L/G1408R, DelF1617/R1632H, and T220I/R1623X) [16], or (b) when other risk factors were present (for example, a Cx40
polymorphism combined with L212P; Table 3) [34]. Notably, when wild-type hNav1.5 channels are expressed from the normal allele, most of the
mutants also caused other cardiac disorders like BrS, AV block, CCD or DCM, as observed for carriers of T187I, W1421X, K1578fs/52, and E161K (see
Discussion and Table 3). In most if not all of these cases, SSS onset relatively late.
doi:10.1371/journal.pone.0010985.g007
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50 kHz (Digidata 1440A; Axon Instruments) and analyzed with a
PC running PCLAMP 10 software (Axon Instruments). All
recordings were made at room temperature (20–22uC).
Expression in Xenopus laevis oocytes
For in vitro transcription, the coding regions of all constructs
were recloned into the pSP64Poly(A) vector (Promega, WI, USA).
The preparation of oocytes from Xenopus laevis, in vitro transcription
and cRNA injection were performed according to established
procedures [37]. For current comparisons, the cRNA concentra-
tion for each variant was adjusted to ,0.04 mg/mL (40 and 60 nL
per oocyte) by dilution. After 3 days of incubation at 18uC in Barth
medium, the whole-cell hNav1.5 peak current amplitude was
usually between 0.5 and 6.0 mA. Measurements were repeated for
at least 5 different batches of oocytes. Whole-oocyte Na
+ currents
were recorded with the two-microelectrode voltage clamp
technique using an OC725C amplifier (Warner Instruments,
Hamden, CT, USA), as previously described [37]. The glass
microelectrodes were filled with 3 mol/L KCl. The microelec-
trode resistance was between 0.2 and 0.5 MV. The bath solution
contained (in mmol/L): NaCl 96, KCl 2, CaCl2 1.8, HEPES 10,
pH 7.2 (KOH).
All experiments involving Xenopus laevis oocytes were prior-
approved by the local government office (Thu ¨ringer Landesamt
Weimar, Fachgebiet Tierschutz, no. 740-2684-04-02-73/96), and
conformed to both institutional and NIH guidelines [38].
Pulse protocols and evaluation of electrophysiological
data from HEK293 cells and oocytes
Steady-state activation was determined by applying test
potentials from 2120 to 50 mV in 5 mV or 10 mV increments
at a pulsing frequency of 0.5 Hz. Data were fitted to the
Boltzmann equation GNa=[1+exp(V1/22V)/k]
21 where V1/2 is
the half-maximal voltage, k is the slope factor, and the Na
+
conductance GNa is defined by GNa=INa,norm/(V2Vrev). Here,
INa,norm is the normalized peak current, and Vrev is the reversal
potential.
Steady-state inactivation was determined with a double pulse
protocol consisting of 500 ms prepulses from the holding potential
of 2120mV (or 2140mV for R1632H only) to voltages between
2140 and 220 mV (or 2160 and 220mV for R1632H only),
followed by a constant test pulse of 20 ms duration to 220 mV at
a pulsing frequency of 0.5 Hz. The amplitude of peak current INa
during the test pulse was normalized to the maximum peak
current INa,max and plotted against the prepulse potential. Data
were fitted with the Boltzmann function INa=INa,max[1+exp(V1/22
V)/k]
21, where V is the test potential, and V1/2 and k are as
defined above.
Recovery from inactivation was determined with a double pulse
protocol consisting of 500 ms prepulses to 220 mV, followed by
variable recovery intervals at 2120 mV, and a constant 20 ms test
pulse to 220 mV at a pulsing frequency of 0.25 Hz (or 0.15 Hz
for R1632H only). The normalized peak current amplitude
(INa,norm=I Na/INa,max) elicited by the test pulse was plotted against
the recovery interval. Data were fitted with 2 exponentials:
INa,norm=A f [12exp(2t/tf)]+As[12exp(2t/ts)], where t is the
recovery time interval, tf and ts represent fast and slow time
constants respectively, and Af and As represent fractional
amplitudes of fast and slow recovery components, respectively.
Cell surface biotinylation and Western blotting
Cell surface biotinylation was performed as described previously
[39]. Briefly, cell membrane proteins were labelled by incubation
(4uC, 30min.) with 1 mg/mL EZ-Link
TM sulfo-NHS-LC-Biotin
(Pierce, IL, USA). Cells were lysed by RIPA buffer (0.5% sodium
deoxycholate, 0.1% SDS, 1% Triton X-100, 50 mmol/L Tris,
150 mmol/L NaCl, and 1 mmol/L EDTA) in the presence of
cocktail protease inhibitors (Roche, IN, USA). Labeled cell-
membrane proteins were precipitated by incubating (4uC, over-
night) cell lysate (200mL) with streptavidin-agarose beads (150mL,
Amersham NJ, USA). The beads were recovered by centrifugation
(15000g, 15min., 4uC), and the supernatant was retained. The
beads were washed with RIPA buffer. Biotinylated cell membrane
proteins were eluted from the beads into Laemmli buffer by
rotation. Both the cell lysate (0.6%) and the purified biotinylated
cell surface proteins (50%) were analysed by SDS-PAGE (6%
acrylamide) followed by Western blotting as previously described
[39,40]. The anti-Nav1.5 antibodies (Alomone, Jerusalem, Israel)
ASC-013 and ASC-005 detected full-length and truncated
channels respectively. Antibody against the endoplasmic reticulum
protein calnexin was used in simultaneous control experiments to
verify that no cytosolic protein had been biotinylated during the
procedure. Results are presented as mean 6 standard error of the
mean (SEM). Statistical analyses were performed using the one-
way ANOVA test with significance being assumed for p,0.05.
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